Hinge Health

HNGE

Market cap $3.87B

This telehealth company offers customized physical therapy sessions through a phone app.

Hinge Health demonstrates robust revenue growth, an expanding client base, and strong cash flow, positioning it well for organic pipeline funding. HNGE's digital MSK therapy platform leverages AI and behavioral support but faces competition, regulatory risks, and heavy reliance on R&D execution. Despite positive non-GAAP operating income and strong liquidity, GAAP losses are inflated by IPO-related stock-based compensation, raising profitability concerns.

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tuesday, November 4, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website.

Hinge Health Co-Founder and CEO Daniel Perez joins 'Mad Money' host Jim Cramer to talk quarterly results, launching an in-person provider network, and more.

Daniel Perez, Hinge Health CEO, joins 'Closing Bell: Overtime' to discuss the company's Q2 earnings, AI initiatives and growth.

Shares of Hinge Health popped after the digital physical therapy company reported quarterly results that beat analysts' estimates for revenue. The company reported quarterly results for the first time since its debut on the New York Stock Exchange in May.

Hinge Health, which went public in May, reported light second-quarter sales. But the IPO stock popped in late trades Tuesday.

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow margin, underlining the market's embrace of our AI-powered platform," said Daniel Perez, Co-Founder and CEO, Hinge Health. "The journey of automating healthcare delivery will be challenging, but we're excited about our momentum and are moving with haste to capture this op.

I rate Hinge Health a buy due to its patented technology, scalable model, and significant untapped market opportunity. TrueMotion's patented, AI-powered platform and FDA-cleared devices create high barriers to entry and enable rapid, cost-effective growth. HNGE's strong partnerships, high client retention, and integration with major health plans drive predictable revenue and market expansion.

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations webs.